What Is an Information Memorandum in Australia?

What is an Information Memorandum (IM)?

An Information Memorandum is a comprehensive document designed to present a detailed overview of a business, investment opportunity, or capital-raising proposal. Its primary purpose is to inform potential stakeholders, enabling them to make an educated decision about engagement or investment.

While the specific content varies depending on the context, a typical IM will summarise key aspects such as:

• The business model and operations
• Financial performance and projections
• Market analysis and growth opportunities
• Management team structure
• Key risks associated with the venture
• The specific terms of the offer (e.g., share price, valuation metrics, assets for sale)

IMs are distinct from formal disclosure documents like prospectuses or product disclosure statements (PDSs), which are subject to more stringent regulatory requirements under the Corporations Act 2001 (Cth). IMs are generally used when an offer falls within one of the disclosure exemptions, allowing for a more flexible and tailored presentation of information.

IMs in Capital Raising

In the context of raising capital, an IM is frequently used to present investment opportunities to a targeted group of potential investors. This approach is particularly common when an offer relies on specific disclosure exemptions under the Corporations Act 2001 (Cth).

Key Disclosure Exemptions

The Corporations Act 2001 (Cth) outlines several exemptions that allow entities to raise capital without preparing a full prospectus or PDS. The most commonly relied-upon exemptions for IMs include:

• Sophisticated Investors (s 708(8)): This exemption applies to offers made to investors who meet specific wealth or income thresholds, or who are certified by a financial services licensee as sophisticated investors. This includes individuals with net assets of at least $2.5 million or gross income of at least $250,000 for each of the last two financial years.
• Professional Investors (s 708(11)): This covers investors who hold an Australian Financial Services (AFS) Licence, or who control gross assets of at least $10 million. These investors are presumed to have the financial expertise to assess offers without the full protection of a prospectus.
• Small-Scale Personal Offers (s 708(1)-(7)): Often referred to as the '20 investors in 12 months' rule, this exemption allows an offeror to make personal offers to no more than 20 investors in any 12-month period, raising no more than $2 million within that same period, without needing a disclosure document. The offer must be a 'personal offer', meaning it is made to a person who is likely to be interested in the offer, and the securities must only be issued to the person to whom the offer was made.
• Offer to Existing Shareholders (s 708(13)): Exempts offers made to existing shareholders of a company who already hold shares in the company.

If an offer does not qualify for an exemption, a regulated disclosure document such as a prospectus, short-form prospectus, or offer information statement, or a product disclosure statement (for managed investment schemes), will be required. These documents are subject to strict content and format requirements imposed by the Australian Securities and Investments Commission (ASIC).

For more information on capital raising and disclosure obligations, refer to ASIC's guidance on fundraising.

For further details on the various methods and legal considerations for raising capital, visit our raising capital page.

IMs in Mergers and Acquisitions (M&A)

In business or share sale transactions, an IM serves as a primary marketing tool for vendors to attract potential buyers. It condenses complex business details into a digestible format, allowing prospective purchasers to quickly understand the opportunity's value proposition.

The M&A Process and the IM

The M&A process often unfolds as follows:

1. Preparation of the IM: The vendor, often with the assistance of financial and legal advisors, compiles the IM.
2. Identification of Potential Buyers: Advisors identify and approach a select group of strategic or financial buyers.
3. Non-Disclosure Agreement (NDA): Before receiving the IM, prospective buyers are typically required to sign a robust NDA. This legally binds them to keep all shared information confidential and use it solely for evaluating the transaction.
4. Distribution of IM: The IM is distributed to NDA-signed prospective buyers.
5. Expression of Interest (EOI): Buyers review the IM and, if interested, submit an EOI or an indicative non-binding offer. This initial offer typically outlines proposed valuation, key assumptions, and proposed deal structure.
6. Due Diligence and Data Room Access: Shortlisted buyers are then granted access to a virtual data room containing more detailed information, such as financial records, business contracts, legal documents, and operational data, to conduct thorough due diligence.
7. Binding Offers: Following due diligence, buyers submit binding offers, leading to negotiations and potentially a sale.

For M&A transactions involving the sale of a business, the IM is crucial for setting the tone for negotiations and attracting serious bidders.

Key Legal Risks and Considerations

While IMs offer flexibility, they carry significant legal risks, primarily concerning the accuracy and completeness of the information presented. Misleading or deceptive conduct can lead to substantial liabilities.

Misleading or Deceptive Conduct

The cornerstone of consumer protection in Australia is found in the Australian Consumer Law (ACL), contained in Schedule 2 of the Competition and Consumer Act 2010 (Cth).

• Section 18 of the ACL: This prohibits a person, in trade or commerce, from engaging in conduct that is misleading or deceptive, or is likely to mislead or deceive. This broad prohibition extends to statements and representations made in an IM, whether in a capital raise or M&A context. Liability under section 18 does not require intent; even an innocent misrepresentation can lead to a breach.
• Section 728 of the Corporations Act 2001 (Cth): Although IMs are often used for offers exempt from full disclosure, this section applies to formal disclosure documents (prospectuses, PDSs). However, the principles underpinning liability for misleading statements in disclosure documents can inform the standard of care expected for IMs, particularly where an IM may be implicitly or explicitly held out as the primary source of information for an investment decision. This section imposes liability on directors, issuing companies, and others for materially false or misleading statements, or material omissions, in a disclosure document.

Directors' and Officers' Liability

Directors and officers involved in the preparation and approval of an IM can face personal liability. This can arise from:

• Breach of Directors' Duties: Under the Corporations Act 2001 (Cth), directors have duties to act with care and diligence (s 180) and not to make improper use of information (s 183). Providing or approving an IM that is known to contain false or misleading information could be a breach of these duties.
• Accessorial Liability: Individuals who are involved in a contravention of the ACL (e.g., section 18) can also be held liable alongside the company. This could include directors, employees, or advisors who knowingly participated in the misleading conduct.

Non-Disclosure Agreements (NDAs)

As mentioned, NDAs are crucial when distributing IMs. These agreements protect the vendor's commercially sensitive information and intellectual property. A robust NDA should clearly define:

• What constitutes confidential information
• Permitted uses of the confidential information
• Restrictions on disclosure to third parties
• Obligations for return or destruction of information
• Duration of confidentiality obligations

For more information on legal obligations concerning fair trading and consumer protection, the Australian Competition and Consumer Commission (ACCC) provides extensive resources.

Drafting and Reviewing an IM

Given the significant legal risks, diligent preparation and review of an IM are paramount. Key considerations include:

• Accuracy and Completeness: All factual statements must be accurate and verifiable. Material omissions can be as misleading as false statements.
• Balanced Presentation: While an IM aims to present an opportunity favourably, it must also disclose key risks and challenges transparently.
• Legal Review: Engaging experienced legal counsel to review the IM is essential. Lawyers can identify potential areas of misleading conduct, ensure compliance with relevant laws, and advise on appropriate disclaimers and protective clauses.
• Financial Verification: Financial data and projections should be prepared by qualified professionals and be consistent with underlying records.
• Risk Disclosure: A dedicated section outlining significant risks associated with the investment or acquisition is critical.

Envision Legal drafts and reviews Information Memoranda for M&A and capital-raising transactions, ensuring both strategic clarity and legal compliance. We also advise on shareholder agreements and other critical legal aspects of business transactions.

This article contains general information only and does not constitute legal advice. Envision Legal accepts no liability for any loss arising from reliance on this content. You should seek independent legal advice tailored to your specific circumstances. For enquiries, contact Envision Legal.